|
|
 |
|
Viewing report
|
|
|
|
China Diagnostic Reagent Market Report, 2007-2009
Research In China, July 2008
1. China's Diagnostic Reagent Market in Globalization Process
1.1 Impact of Globalization on China's Medicine Market
1.1.1 Pharmaceutical Industry Restructuring and International Division of Labor
1.1.2 Accelerated Globalization Process of Pharmaceutical Market
1.1.3 International Status of China Pharmaceutical Industry
1.1.4 Forecast of China Status in Global Pharmaceutical Industry, 2009
1.2. Safety Factors of Economic Globalization, 2009
1.2.1 Developing Countries Participation in Economic Globalization
1.2.2 Strategy of Economic Globalization Launched by Developed Nations
1.2.3 Impact of Globalization on Economic Safety of Developing Nations
2. Industrialization of Reagent for Clinical Diagnosis
2.1 Present Situation of China's Diagnostic Reagent Sector
2.2 Prospect of China's Diagnostic Reagent Market
2.3 Scale of China's Diagnostic Reagent Market
2.4 China's Diagnostic Reagent Producers
2.5 Countermeasures of China's Diagnostic Reagent Sector
2.5.1 Development Features of China Diagnostic Reagent Market
2.5.2 Challenges and Opportunities
2.5.3 Development Trend of China Diagnostic Market
3. Clinical Diagnostic Reagent R&D
3.1 Development of Medical Inspection and Reagent for Clinical Diagnosis
3.2 Main Reagents for Clinical Diagnosis
3.2.1 Biochemical Reagent
3.2.2 Immunity Reagent
3.2.3 Molecular Diagnostic Reagent
3.2.4 Other Reagents Market
4. China's Diagnostic Reagent Market in 2008
4.1 Production Capacity of China's Diagnostic Reagent Sector
4.1.1 Producers
4.1.2 Market Size
4.1.3 Research and Development
4.2 Segmented Market
4.3 Market Capacity
4.4 Hospital Channels
4.4.1 Policy and Mode of Purchasing Medicine with Central Bidding
4.4.2 Hospital's Procurement and Management of Diagnostic Reagent
5. Segmented Market of Diagnostic Reagent
5.1 Cardiovascular Diagnostic Reagent
5.1.1 Background and Reasons of Cardiovascular Disease
5.1.2 Relationship between Nutrition and Cardiovascular Disease
5.1.3 Genetic Revolution of Cardiovascular Diagnosis
5.1.4 Incidence of Cardiovascular Disease
5.1.5 New Stage of Cardiovascular Disease Prevention
5.1.6 New Mode of Cardiovascular Disease Prevention
5.1.7 Market of Test Reagent for the Detection of Cardiovascular Disease
5.2 Venereal Diagnostic Reagent
5.2.1 AIDS Incidence in China
5.2.2 Anti-AIDS Medicine Market
5.2.2.1 Overview of International Anti-AIDS Medicine Market
5.2.2.2 Clinical Application of Anti-AIDS Medicine in China
5.2.3 Incidence Rate of Venereal Disease and Morbidity Situation
5.2.4 Market Capacity of Venereal Disease Test Reagent
5.3 Hepatitis Diagnostic Reagent
5.3.1 Market of Test Reagent for the Detection of Hepatitis
5.4 Test Reagent for the Detection of Tumor
5.4.1 Tumor Markers and Clinical Application
5.4.1.1 Common Tumor Markers
5.4.1.2 Clinical Application of Various Tumor Markers
5.4.1.3 Incidence Rate of Tumor and Morbidity Situation
5.4.1.4 Future Direction of Cancer Diagnosis and Treatment
5.5 SARS Diagnostic Reagent R&D
5.6 HTLV Market and HTLV R&D
5.6.1 Introduction of HTLV
5.6.1.2 Overseas Application of HTLV Test
5.6.1.3 HTLV Test Reagent of WIT
6. China's Diagnostic Reagent Import and Export
6.1 Import and Export
6.2 Global Diagnostic Reagent Export Structure
6.3 Regional Structure of Diagnostic Reagent Export in China
6.4 Trade Mode
7. Diagnostic Reagent Producers
7.1 Overall Situation
7.2 Roche
7.2.1 Company Profile
7.2.2 Operation Status in 2008
7.2.3 Development Strategy
7.2.4 China in List of Nations for Roche Research and Development
7.2.5 Roche's Cancer Medicine Development
7.3 Abbott
7.3.1 Company Profile
7.3.2 Operation Status
7.4 Johnson and Johnson
7.4.1 Company Profile
7.4.2 Operation Status in 2008
7.4.3 Building A R&D Center in Shanghai
7.4.4 Building A Biopharmaceutical Plant in Ireland
7.5 GlaxoSmithKline
7.5.1 Company Profile
7.5.2 Operation Status in 2008
7.5.3 Development Strategy
7.6 Pfizer
7.6.1 Company Profile
7.6.2 Company Profile
8. Domestic Key Enterprises, 2008-2009
8.1 FOSUN Pharmaceuticals (Group) Corporation
8.1.1 Company Profile
8.1.2 Operation Status
8.1.3 Development Strategy
8.2 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
8.2.1 Company Profile
8.3 Shanghai Rongsheng Biotech Co., Ltd.
8.4 Shanghai Kehua Bio-engineering Co., Ltd.
8.4.1 Company Profile
8.4.2 Operation Status
8.5 Nanjing Jiancheng Bioengineering Institute
8.6 Livzon Syntpharm Co., Ltd. (Zhuhai FTZ)
8.6.1 Company Profile
8.6.2 Operation Status
8.7 Joint Ventures
8.7.1 Shanghai Fosun Long March Medical Science Co. Ltd.
8.7.2 Huamei Biological Engineering Co. Ltd.
8.8 Import Agents
8.8.1 Huasin Science Co. Ltd.
8.8.2 Beijing Bitab Biotech Co. Ltd.
8.8.3 Dalian Fanbang Chemical Technology Development Co. Ltd.
9. Development Trend of China's Diagnostic Reagent in 2009
9.1 Chinese Government Pays Much Attention To Developing Diagnostic Reagent
9.1.1 Regulate Management of Diagnostic Reagents
9.1.2 Approval and Registration of Diagnostic Reagents According to Law
9.1.3 Strengthening Supervision & Check of Diagnostic Reagents
9.1.4 Import & Export Policy
9.2 Prospect of China's Diagnostic Reagent Development in 2009
9.2.1 Profitability and Growth of Diagnostic Reagent Sector
9.2.1.1 Development Prospect of Diagnostic Reagent Sector
9.2.1.2 Market Entry Barriers to Diagnostic Reagent Sector
9.2.1.3 Role of Gene Technology in Development of Diagnostic Reagent
9.2.2 Factors Affecting Development of Diagnostic Reagent Market
9.2.3 Development Trend of Diagnostic Reagents in 2009
9.2.4 Forecast of Output Value of Industrial Microbiological Test Reagents
9.2.5 Market Prospect of Vitro Diagnostic Reagents in 2009
9.2.6 Market Prospect of Diagnostic Reagent for Diabetes in 2009
9.2.7 Market Prospect of Anti-AIDS Medicine in 2009
9.2.8 Development Prospect of China Biopharmaceutical Market
9.2.9 Development Trend of Key Biopharmaceutical Technology in 2009
10. Strategies for Entering Diagnostic Reagent Market in 2009
10.1 Countermeasures about Products
10.2 Countermeasures about Market Competition
10.2.1 Capacity Expansion by Mergers and Restructuring
10.2.2 Regional General Distribution System
10.2.3 Targeting the International GMP Pass
10.3 Market Entry Procedure and Investment in the Market
10.3.1 Product Quality Standards and Market Entry Examination
10.3.2 Investment in Diagnostic Reagents
11. Technical Environment - Global Biological Technology Market
11.1 Market Prospect
11.1.1 Biological Technology Industry Development
11.1.2 Diagnostic Reagent Market
11.1.3 Forecast of Nucleic Acid Reagent Market
11.2 U.S.A. Market
11.2.1 Number and Size of Biological Technology Companies
11.2.2 R&D Funds in Biological Technology Market
11.2.3 Scale of Consumption
12. Economic Environment - China Biopharmaceutical Industry Development
12.1 Operation of China's Biopharmaceutical Industry in 2007
12.1.1 Changes in Output Value of China Biopharmaceutical Industry in 2007
12.1.2 Changes in the Number of China Biopharmaceutical Companies in 2007
12.1.3 Operation of China Biopharmaceutical Companies in 2007
12.1.4 Asset - Liability of China Biopharmaceutical Companies in 2007
12.1.5 Sales & Expenditure Cost of China Biopharmaceutical Firms in 2007
12.1.6 Profitability of China Biopharmaceutical Companies in 2007
12.1.7 Changes in Ownership Structure of Biopharmaceutical Industry in 2007
12.1.8 Size Structure of China Biopharmaceutical Industry in 2007
List of Charts
Top 10 Diagnostic Reagent Producers in Terms of Sales and Market Share
Clinical Biological Reagent for Determination
Common EIA Reagent
Common Colloidal Gold Reagent
Common Chemiluminescence Reagent
Market Situation of Some Major Immunity Reagents
The Number of China's Diagnostic Reagent Companies
Ratio of Diagnostic Reagent Expense to the Total Diagnostic Expense
Market Share of Clinical Chemistry in Diagnostic Reagent Market
Market Share of Household Use of Diagnostic Reagent
Main Cardiovascular Diagnostic Reagents in China’s Market
Market Share of Foreign Diagnostic Reagent in China's HIV Market
Ratio of Wantai HIV Diagnostic Reagent Output to the National Total
Hepatopathy Morbidity and Death Toll in China, Dec. 2007
Some Hepatitis Diagnostic Reagents in China
Clinical Application of Joint Detection of Common Tumor Markers
X-Ray Contrast Agent Import in Aug. 2007
X-Ray Contrast Agent Export in Aug. 2007
Import Value of Diagnostic Reagent, 2006-2007
Import & Export Value of Diagnostic Reagent in 2007
Comparison of Import Value of Diagnostic Reagent Between 2006 and 2007
Import & Export Volume of Diagnostic Reagent in 2007
Contrast of Export Value of Diagnostic Reagent Between 2006 and 2007
Contrast of Export Volume of Diagnostic Reagent Between 2006 and 2007
Contrast of Import Value of Diagnostic Reagent Between 2007 and 2008
Contrast of Import Volume of Diagnostic Reagent Between 2007 and 2008
Contrast of Export Value of Diagnostic Reagent Between 2007 and 2008
Contrast of Export Volume of Diagnostic Reagent Between 2007 and 2008
Global Monthly Diagnostic Reagent Export in Different Regions, 2007
China Top 10 Regions in Terms of Diagnostic Reagent Export Volume, 2007
China Top 10 Regions in Terms of Diagnostic Reagent Export Value, 2007
China Monthly Diagnostic Reagent Export in Different Regions, 2007
Import Volume & Value of Diagnostic Reagent Donated by Foreign Countries and International Organizations
Top 10 Pharmaceutical Giants, 2007
Forbes Top 10 Pharmaceutical Producers, 2007 (US$100 million)
Sales Revenue and Net Profit of Pharmaceutical Giants, 1Q2008
Global Pharmaceutical Market Growth, 2008
Sales Revenue Increase of Roche, Q1 2008
Rises in Prescription Drug Sales Revenue of Abbott, Q1 2008
Profitability of Johnson & Johnson, 2007-2008
Operating Ability of Johnson & Johnson, 2007-2008
Debt-paying Ability of Johnson & Johnson, 2007-2008
Capital Structure of Johnson & Johnson, 2007-2008
Development Ability of Johnson & Johnson, 2007-2008
Cash Flow of Johnson & Johnson, 2007-2008
Rankings of Pharmaceutical Producers among Fortune Global 500 Companies
Prescription Drug Sales Revenue of Pfizer, Q1 2008
Sales Revenue of Celecoxib and Celebrex in Pfizer, Q1 2008
GlaxoSmithKline Sales Revenue, Q1 2008
Anti-AIDS Medicine Sales Revenue of GlaxoSmithKline, Q1 2008
Subsidiaries Controlled by FOSUN
Companies Controlled by Subsidiaries of FOSUN
Profitability of FOSUN, 2007-2008
Operating Ability of FOSUN, 2007-2008
Debt-paying Ability of FOSUN, 2007-2008
Capital Structure of FOSUN, 2007-2008
Development Ability of FOSUN, 2007-2008
Cash Flow of FOSUN, 2007-2008
Main Products of Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Diagnostic Reagents of Wantai Biological Pharmacy Enterprise Co., Ltd.
Development Process of Shanghai Rongsheng Biotech Co., Ltd.
Development Process of Shanghai Kehua Bio-engineering Co., Ltd.
Subsidiaries of Shanghai Kehua Bio-engineering Co., Ltd.
R&D Process of Shanghai Kehua Bio-engineering Co., Ltd.
Revenue of Main Vitro Clinical Immunity Reagents of Shanghai Kehua
Profitability of Shanghai Kehua Bio-engineering Co., Ltd., 2007-2008
Operating Ability of Shanghai Kehua Bio-engineering Co., Ltd., 2007-2008
Debt-paying Ability of Shanghai Kehua Bio-engineering Co., Ltd., 2007-2008
Capital Structure of Shanghai Kehua Bio-engineering Co., Ltd., 2007-2008
Development Ability of Shanghai Kehua Bio-engineering Co., Ltd., 2007-2008
Cash Flow of Shanghai Kehua Bio-engineering Co., Ltd., 2007-2008
Projects Financed by Fund Raising of Shanghai Kehua Bio-engineering Co.
Main Diagnostic Reagents of Nanjing Jiancheng Bioengineering Institute
Associated Companies of Livzon
Profitability of Livzon, 2007-2008
Operating Ability of Livzon, 2007-2008
Debt-paying Ability of Livzon, 2007-2008
Capital Structure of Livzon, 2007-2008
Development Ability of Livzon, 2007-2008
Cash Flow of Livzon, 2007-2008
Global Top 10 Diagnostic Reagent Manufacturers
Market and R&D of American Biological Industry
Consumption Scale of American Diagnostic Reagent Market
Top 5 Nations in Terms of Market Share in Global Diagnostic Reagent Market Output Value of China's Biopharmaceutical Industry, 2007
The Number of China's Biopharmaceutical Companies, 2007
Operation Indices of China’s Biopharmaceutical Industry, 2007
Balance Sheet of China's Biopharmaceutical Industry, 2007
Sales Revenue of China's Biopharmaceutical Industry, 2007
Production Expenses of China’s Biopharmaceutical Industry, 2007
Profit and Tax of China's Biopharmaceutical Industry, 2007
This title is also available in the following language
China Diagnostic Reagent Market Report, 2007-2009 (Chinese Version)
Customers who bought this item also bought
China Diagnostic Reagent Market Report, 2007-2009
Research Report of Chinese Diagnostic Reagent Industry, 2009
Hematology Analyzer Instrumentation and Reagent Markets
China Biopharmaceutical Industry Report, 2007-2008
China Biopharmaceutical Industry Report, 2007-2008
Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
Company Study of Shanghai Kehua Bio-engineering Co., Ltd., 2007
Company Study of Shanghai Kehua Bio-engineering Co., Ltd. 2007
Point of Care Diagnostic Testing World Markets
Chinese Markets for Diagnostic Reagents
High-Growth Diagnostic Testing Markets
Market Report on China’s Biopharmaceutical Industry, 2008-2010
|
|
|
|
